Author

N. Weissmann

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Organism:mouse· 2 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:metagenomics· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Birnhuber· 1 shared A. Dietrich· 1 shared A.-S. Schultz· 1 shared B. Seeliger· 1 shared c. grimm· 1 shared C. Samakovlis· 1 shared C.-M. Chao· 1 shared F. Kurth· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

A. Birnhuber

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

FGF10 triggers de novo alveologenesis in a BPD model: impact on the resident mesenchymal niche cells

S. Taghizadeh, C.-M. Chao, S. Guenther, L. Glaser, L. Gersmann, G. Michel, S. Kraut, K. Goth, J. Koepke, S. Herold, C. Samakovlis, N. Weissmann, g. Aquila, F. Ricci, L. Boyer, , S. Rivetti

This study shows that FGF10 administration rescues alveologenesis defects in a BPD mouse model by activating resident mesenchymal niche cells.

bioRxiv · Mar 14, 2022Cell Biology

Altered fibrin clot structure contributes to thrombosis risk in severe COVID-19

M. Wygrecka, A. Birnhuber, B. Seeliger, L. Michalick, O. Pak, A.-S. Schultz, F. Schramm, M. Zacharias, G. Gorkiewicz, S. David, T. Welte, J. J. Schmidt, N. Weissmann, R. T. Schermuly, G. Barreto, , K. T. Preissner

The paper shows that altered fibrin clot structure in severe COVID-19 patients contributes to thrombosis risk by forming compact, fibrinolysis-resistant clots.

bioRxiv · Sep 17, 2021Biochemistry

Transient receptor vanilloid 4 (TRPV4) channels are essential for alveolar epithelial cell function

J. Weber, Y.-K. Chao, M. Kannler, G. Krasteva-Christ, S. Rajan, O. A. Yildirim, M. Brosien, J. Schredelseker, N. Weissmann, c. grimm, T. Gudermann, A. Dietrich

This study shows TRPV4 channels protect alveolar epithelial barriers by maintaining AQP-5 and pSP-C expression, preventing edema during ischemia-reperfusion.

JCI Insight · Oct 15, 2020Peer-reviewedCell Biology